{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:24:01Z","timestamp":1778552641989,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA21111"],"award-info":[{"award-number":["CA21111"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["UID 84627"],"award-info":[{"award-number":["UID 84627"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["CEECIND\/CP1663\/CT0004"],"award-info":[{"award-number":["CEECIND\/CP1663\/CT0004"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016962","name":"Department of Science and Innovation, South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118095","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:05:14Z","timestamp":1756479914000},"page":"118095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["From pan-active to parasite-selective antiparasitic agents: A scaffold hopping approach"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-8362","authenticated-orcid":false,"given":"Chiara","family":"Borsari","sequence":"first","affiliation":[]},{"given":"Nuno","family":"Santarem","sequence":"additional","affiliation":[]},{"given":"Dina","family":"Coertzen","sequence":"additional","affiliation":[]},{"given":"Asia","family":"Mazzolari","sequence":"additional","affiliation":[]},{"given":"Alexandra Ioana","family":"Corfu","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"Francisca","family":"Barbosa","sequence":"additional","affiliation":[]},{"given":"Lucia","family":"Tamborini","sequence":"additional","affiliation":[]},{"given":"Lyn-Mari\u00e9","family":"Birkholtz","sequence":"additional","affiliation":[]},{"given":"Lorenzo","family":"Raffellini","sequence":"additional","affiliation":[]},{"given":"Oliver","family":"Keminer","sequence":"additional","affiliation":[]},{"given":"Nicoletta","family":"Basilico","sequence":"additional","affiliation":[]},{"given":"Silvia","family":"Parapini","sequence":"additional","affiliation":[]},{"given":"Sheraz","family":"Gul","sequence":"additional","affiliation":[]},{"given":"Anabela","family":"Cordeiro-da-Silva","sequence":"additional","affiliation":[]},{"given":"Paola","family":"Conti","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118095_bib1","first-page":"137","article-title":"Parasitic diseases in humans transmitted by vectors","volume":"61","author":"Cholewi\u0144ski","year":"2015","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.ejmech.2025.118095_bib2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3390\/molecules22030426","article-title":"Chroman-4-One derivatives targeting pteridine reductase 1 and showing anti-parasitic activity","volume":"22","author":"Di Pisa","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118095_bib3","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human african trypanosomiasis","volume":"390","author":"B\u00fcscher","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.118095_bib4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/acsinfecdis.8b00358","article-title":"Structural insights into the development of cycloguanil derivatives as trypanosoma brucei pteridine-reductase-1 inhibitors","volume":"5","author":"Landi","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118095_bib5","series-title":"Annual Reports in Medicinal Chemistry","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/bs.armc.2018.08.002","article-title":"Chapter two - scaffolds and biological targets avenue to fight against drug resistance in leishmaniasis","author":"Borsari","year":"2018"},{"key":"10.1016\/j.ejmech.2025.118095_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI33945","article-title":"Kinetoplastids: related protozoan pathogens, different diseases","volume":"118","author":"Stuart","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.118095_bib8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41579-024-01026-0","article-title":"Effects of climate change and human activities on vector-borne diseases","volume":"22","author":"de Souza","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118095_bib9","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.3390\/ijms20225748","article-title":"An overview of drug resistance in Protozoal diseases","volume":"20","author":"Capela","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118095_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41579-024-01099-x","article-title":"Towards next-generation treatment options to combat Plasmodium falciparum malaria","volume":"23","author":"Okombo","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118095_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pt.2023.01.010","article-title":"Drug discovery for parasitic diseases: powered by technology, enabled by pharmacology, informed by clinical science","volume":"39","author":"Rao","year":"2023","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2025.118095_bib12","first-page":"61","article-title":"Development and introduction of fexinidazole into the global human african trypanosomiasis program","volume":"106","author":"Valverde Mordt","year":"2022","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2025.118095_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay071","article-title":"Tafenoquine receives regulatory approval in USA for prophylaxis of malaria and radical cure of Plasmodium vivax","volume":"25","author":"Tan","year":"2018","journal-title":"J. Trav. Med."},{"key":"10.1016\/j.ejmech.2025.118095_bib14","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1021\/jm400362b","article-title":"Drug discovery for neglected diseases: molecular target-based and phenotypic approaches","volume":"56","author":"Gilbert","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118095_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111676","article-title":"Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics","volume":"183","author":"Borsari","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118095_bib16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acsmedchemlett.8b00565","article-title":"SAR studies and biological characterization of a chromen-4-one derivative as an anti-trypanosoma brucei agent","volume":"10","author":"Borsari","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118095_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/cmdc.201700786","article-title":"Development of a focused library of triazole-linked privileged-structure-based conjugates leading to the discovery of novel phenotypic hits against Protozoan parasitic infections","volume":"13","author":"Uliassi","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118095_bib18","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.3390\/molecules26144204","article-title":"Design, synthesis and antiparasitic evaluation of click phospholipids","volume":"26","author":"Magoulas","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118095_bib19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-022-00472-w","article-title":"Phenotypic drug discovery: recent successes, lessons learned and new directions","volume":"21","author":"Vincent","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118095_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1473-3099(22)00660-0","article-title":"Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2\/3 trial","volume":"23","author":"Betu Kumeso","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118095_bib21","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/cid\/ciab716","article-title":"Efficacy of cipargamin (KAE609) in a randomized, phase II dose-escalation study in adults in Sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria","volume":"74","author":"Schmitt","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118095_bib22","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1021\/acsinfecdis.4c00181","article-title":"Discovery of 1,3,4-oxadiazole derivatives as broad-spectrum antiparasitic agents","volume":"10","author":"Corfu","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118095_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103845","article-title":"Molecular medicinal insights into scaffold hopping-based drug discovery success","volume":"29","author":"Acharya","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.118095_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/cmdc.201500496","article-title":"Inspired by nature: the 3-Halo-4,5-dihydroisoxazole moiety as a novel molecular warhead for the design of covalent inhibitors","volume":"11","author":"Pinto","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118095_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115286","article-title":"Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells","volume":"254","author":"Galbiati","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118095_bib26","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3390\/molecules24132470","article-title":"Amidoximes and oximes: synthesis, structure, and their key role as NO donors","volume":"24","author":"Sahyoun","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118095_bib27","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0040-4039(00)02288-7","article-title":"Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst","volume":"42","author":"Gangloff","year":"2001","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.118095_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0040-4039(00)99918-0","article-title":"A short, efficient total synthesis of (\u00b1) acivicin and (\u00b1) bromo-acivicin","volume":"25","author":"Vyas","year":"1984","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.118095_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118095_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejmech.2019.07.010","article-title":"4-Aminoquinoline-based compounds as antileishmanial agents that inhibit the energy metabolism of Leishmania","volume":"180","author":"Manzano","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118095_bib31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.trstmh.2008.01.021","article-title":"Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates","volume":"102","author":"Rason","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2025.118095_bib32","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118095_bib33","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/AAC.03265-14","article-title":"Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains","volume":"59","author":"Chugh","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118095_bib34","doi-asserted-by":"crossref","first-page":"E1214","DOI":"10.1073\/pnas.1112037108","article-title":"Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue","volume":"108","author":"Adjalley","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.118095_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.926460","article-title":"Streamlined and robust stage-specific profiling of gametocytocidal compounds against Plasmodium falciparum","volume":"12","author":"Reader","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118095_bib36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118095_bib37","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1021\/acs.jmedchem.6b00698","article-title":"Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs","volume":"59","author":"Borsari","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118095_bib38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/ml1002629","article-title":"Inhibitory effect of silver nanoparticles on trypanothione reductase activity and Leishmania infantum proliferation","volume":"2","author":"Baiocco","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118095_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.1993.48.205","article-title":"Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia","volume":"48","author":"Makler","year":"1993","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2025.118095_bib40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ejmech.2025.118095_bib41","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1021\/ac502098w","article-title":"Multicolor bioluminescence boosts malaria research: quantitative dual-color assay and single-cell imaging in Plasmodium falciparum parasites","volume":"86","author":"Cevenini","year":"2014","journal-title":"Anal. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:05:46Z","timestamp":1772827546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"alternative-id":["S0223523425008608"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118095","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From pan-active to parasite-selective antiparasitic agents: A scaffold hopping approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118095"}}